| Financial Year |
March 31 2023 |
| Monetary Funds |
190,909,576.07 |
| Held-for-trading Financial Assets |
20,868,192.01 |
| Notes Receivable |
132,363,858.57 |
| Accounts Receivable |
326,448,672.87 |
| Advances to Suppliers |
8,012,892.87 |
| Other Receivables |
101,001,782.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
145,383,839.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,617.20 |
| Total Current Assets |
964,975,866.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
246,600,360.92 |
| Under-construction Projects |
3,127,252.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,131,717.27 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
4,602,670.82 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
340,012,059.27 |
| Total Assets |
1,304,987,926.24 |
| Short-Term Loans |
35,042,716.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
73,010,000.00 |
| Accounts Payable |
127,499,529.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,500,576.47 |
| Taxes Payable |
17,702,070.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,154,014.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
702,172.20 |
| Other Current Liabilities |
27,367.65 |
| Sub-Total of Current Liabilities |
281,848,967.09 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,916,287.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,741,524.38 |
| Total Liabilities |
294,590,491.47 |
| Paid-In Capital(Or Share Stock) |
180,357,032.00 |
| Capital Surplus |
406,982,091.29 |
| Surplus Reserve |
64,024,581.98 |
| LESS:Treasury Stock |
63,572,234.90 |
| Undistributed Profits |
414,092,337.55 |
| Minority Stockholder's Interest |
8,513,626.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,001,883,807.92 |
| Owner's Equity（Stockholder's Equity） |
1,010,397,434.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,304,987,926.24 |
